← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #245 OF 1,000 MOST-CITED

Records - returned dietary supplement: written procedures

FDA cited this observation 89 times across 82 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods89
BY FISCAL YEAR
FY20248
FY202318
FY202211
FY20216
FY20203
FY201910
FY201822
FY201711

How FDA worded it — real examples

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

Inca Living Corp · Boca Raton, Florida · Foods · 2024-06-24

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

Selery Fulfillment · Orlando, Florida · Foods · 2024-05-31

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

VBS Distribution, Inc · Westminster, California · Foods · 2024-04-18

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

Warner Herb Co. · Crossville, Tennessee · Foods · 2024-02-27

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

Western Innovations, Inc. · Denver, Colorado · Foods · 2024-02-21

You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

GO Life Corporation · San Juan, Puerto Rico · Foods · 2024-01-23

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →